Insulet Corp. Insulet Corp.

Insulet Corp.

PODD

Clasificación en acciones #2094
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Precio por acción
$141.47
Última sincronización: 2026-10-19
Capitalización bursátil
$9.81B
Cambio (1 día)
0.26%
Cambio (1 año)
-56.72%
País
US
Comercio Insulet Corp. (PODD)

Categoría

Healthcare
Historial de desdoblamientos de acciones de Insulet Corp. (PODD)
La acción Insulet Corp. (símbolo: PODD) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Oct 20, 2026.
Una acción PODD comprada antes de Oct 20, 2026 equivaldría hoy a 0 acciones PODD.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
9 x285
US
7 x127
IE
9 x162
US
2 x4
US
0 -
DE